DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for dutasteride; tamsulosin hydrochloride and what is the scope of freedom to operate?
Dutasteride; tamsulosin hydrochloride
is the generic ingredient in two branded drugs marketed by Actavis Labs Fl Inc, Aurobindo Pharma, Endo Operations, Zydus Pharms, and Waylis Therap, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.Six suppliers are listed for this compound.
Summary for DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 5 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 6 |
Clinical Trials: | 21 |
DailyMed Link: | DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Beth Israel Deaconess Medical Center | N/A |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | N/A |
Ministry of Health, France | Phase 3 |
See all DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE clinical trials
Pharmacology for DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
Drug Class | 5-alpha Reductase Inhibitor alpha-Adrenergic Blocker |
Mechanism of Action | 5-alpha Reductase Inhibitors Adrenergic alpha-Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
Paragraph IV (Patent) Challenges for DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
JALYN | Capsules | dutasteride; tamsulosin hydrochloride | 0.5 mg/0.4 mg | 022460 | 1 | 2010-10-26 |
US Patents and Regulatory Information for DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
Expired US Patents for DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Waylis Therap | JALYN | dutasteride; tamsulosin hydrochloride | CAPSULE;ORAL | 022460-001 | Jun 14, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Waylis Therap | JALYN | dutasteride; tamsulosin hydrochloride | CAPSULE;ORAL | 022460-001 | Jun 14, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Waylis Therap | JALYN | dutasteride; tamsulosin hydrochloride | CAPSULE;ORAL | 022460-001 | Jun 14, 2010 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.